Bank of America’s Sonnet BioTherapeutics SONN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,784
| Closed | -$76.9K | – | 8247 |
|
|
2025
Q3 | $76.9K | Buy |
16,784
+16,755
| +57,776% | +$74.3K | ﹤0.01% | 6700 |
|
|
2025
Q2 | $36 | Buy |
29
+3
| +12% | +$4 | ﹤0.01% | 8164 |
|
|
2025
Q1 | $35 | Buy |
26
+21
| +420% | +$32 | ﹤0.01% | 8040 |
|
|
2024
Q4 | $7 | Buy |
+5
| New | +$17 | ﹤0.01% | 8107 |
|
|
2024
Q3 | – | Sell |
-4
| Closed | -$27 | – | 8389 |
|
|
2024
Q2 | $27 | Buy |
4
+3
| +300% | +$40 | ﹤0.01% | 7949 |
|
|
2024
Q1 | $11 | Buy |
+1
| New | +$13 | ﹤0.01% | 7541 |
|
|
2023
Q4 | – | Sell |
-12
| Closed | -$270 | – | 8208 |
|
|
2023
Q3 | $270 | Buy |
+12
| New | +$630 | ﹤0.01% | 7378 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7663 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7733 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8163 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8171 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8352 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8716 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8604 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8372 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8063 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7747 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7348 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7149 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7107 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6649 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6844 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6900 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6822 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6685 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6709 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6600 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6569 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6379 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6591 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6514 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6358 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6419 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6381 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6056 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6294 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5136 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5236 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$1.18M | – | 5117 |
|
|
2015
Q2 | $996K | Buy |
+1
| New | +$1.88M | ﹤0.01% | 4116 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5220 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6509 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6594 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6573 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6129 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 6026 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5946 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 6427 |
|
Other funds holding SONN
Bank of America's SONN Position: Q4 2025 in Review
Bank of America sold out of Sonnet BioTherapeutics (SONN) in Q4 2025, closing a stake of 16,784 shares — an estimated $76.9K sold.
Bank of America first reported a position in SONN in Q2 2015 and held it in 8 quarters. The position peaked at $996K in Q2 2015. 1 fund tracked by Wall St. Rank holds SONN as of Q4 2025.
- Bank of America reported no remaining Sonnet BioTherapeutics position as of Q4 2025 after selling out during the quarter.
- Bank of America sold 16,784 Sonnet BioTherapeutics shares in Q4 2025, an estimated $76.9K.
- Bank of America first reported a position in Sonnet BioTherapeutics in Q2 2015 and held it in 8 quarters.
- Bank of America's Sonnet BioTherapeutics position peaked at $996K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Sonnet BioTherapeutics as of Q4 2025.
Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.